{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:51:59Z","timestamp":1789015919410,"version":"build-2803163510"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1097\/cad.0000000000000039","type":"journal-article","created":{"date-parts":[[2013,12,20]],"date-time":"2013-12-20T10:02:21Z","timestamp":1387533741000},"page":"150-160","source":"Crossref","is-referenced-by-count":25,"title":["Anticancer effect of bromelain with and without cisplatin or 5-FU on malignant peritoneal mesothelioma cells"],"prefix":"10.1097","volume":"25","author":[{"given":"Krishna","family":"Pillai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahid","family":"Ehteda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javid","family":"Akhter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence C.","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-3-20210227","first-page":"162","article-title":"Latency periods in asbestos-related mesothelioma of the pleura.","volume":"6","author":"Bianchi","year":"1997","journal-title":"Eur J Cancer Prev"},{"key":"R3-3-20210227","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/(SICI)1096-9098(199901)70:1<6::AID-JSO2>3.0.CO;2-X","article-title":"Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma.","volume":"70","author":"Eltabbakh","year":"1999","journal-title":"J Surg Oncol"},{"key":"R4-3-20210227","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma.","volume":"366","author":"Robinson","year":"2005","journal-title":"Lancet"},{"key":"R5-3-20210227","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.3747\/co.v18i2.663","article-title":"A new standard of care for the management of peritoneal surface malignancy.","volume":"18","author":"Mohamed","year":"2011","journal-title":"Curr Oncol"},{"key":"R8-3-20210227","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0959-8049(03)00233-8","article-title":"Analysis of survival of mesothelioma cases in the Italian register (ReNaM).","volume":"39","author":"Marinaccio","year":"2003","journal-title":"Eur J Cancer"},{"key":"R11-3-20210227","doi-asserted-by":"crossref","first-page":"303","DOI":"10.5301\/JBM.5000038","article-title":"MUC1 has prognostic significance in malignant peritoneal mesothelioma.","volume":"28","author":"Pillai","year":"2013","journal-title":"Int J Biol Markers"},{"key":"R17-3-20210227","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4161\/cbt.6.4.4201","article-title":"MUC1: a target molecule for cancer therapy.","volume":"6","author":"Singh","year":"2007","journal-title":"Cancer Biol Ther"},{"key":"R18-3-20210227","first-page":"905","article-title":"Advances of MUC1 as a target for breast cancer immunotherapy.","volume":"22","author":"Yang","year":"2007","journal-title":"Histol Histopathol"},{"key":"R20-3-20210227","first-page":"1643","article-title":"Targeting cysteine-mediated dimerization of the MUC1-C oncoprotein in human cancer cells.","volume":"40","author":"Raina","year":"2012","journal-title":"Int J Oncol"},{"key":"R21-3-20210227","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1006\/bbrc.2001.4775","article-title":"Identification of MUC1 proteolytic cleavage sites in vivo.","volume":"283","author":"Parry","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"R23-3-20210227","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nsmb1035","article-title":"Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucin.","volume":"13","author":"Macao","year":"2006","journal-title":"Nat Struct Mol Biol"},{"key":"R24-3-20210227","doi-asserted-by":"crossref","first-page":"12820","DOI":"10.1016\/S0021-9258(18)37632-4","article-title":"A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats.","volume":"263","author":"Gendler","year":"1988","journal-title":"J Biol Chem"},{"key":"R25-3-20210227","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1023\/A:1011379725811","article-title":"MUC1, the renaissance molecule.","volume":"6","author":"Gendler","year":"2001","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"R26-3-20210227","doi-asserted-by":"crossref","first-page":"45721","DOI":"10.1074\/jbc.M408027200","article-title":"MUC1 oncoprotein activates the FOXO3a transcription factor in a survival response to oxidative stress.","volume":"279","author":"Yin","year":"2004","journal-title":"J Biol Chem"},{"key":"R27-3-20210227","doi-asserted-by":"crossref","first-page":"13057","DOI":"10.1074\/jbc.M011248200","article-title":"Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland.","volume":"276","author":"Schroeder","year":"2001","journal-title":"J Biol Chem"},{"key":"R29-3-20210227","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1158\/1541-7786.MCR-06-0204","article-title":"MUC1 oncoprotein functions in activation of fibroblast growth factor receptor signaling.","volume":"4","author":"Ren","year":"2006","journal-title":"Mol Cancer Res"},{"key":"R31-3-20210227","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4161\/cbt.7.1.5631","article-title":"Targeting the human MUC1 oncoprotein: a tale of two proteins.","volume":"7","author":"Kufe","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"R32-3-20210227","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0076-6879(94)44040-9","article-title":"Pineapple cysteine endopeptidases.","volume":"244","author":"Rowan","year":"1994","journal-title":"Methods Enzymol"},{"key":"R33-3-20210227","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1007\/PL00000936","article-title":"Bromelain: biochemistry, pharmacology and medical use.","volume":"58","author":"Maurer","year":"2001","journal-title":"Cell Mol Life Sci"},{"key":"R34-3-20210227","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1016\/j.biortech.2007.08.035","article-title":"Reclamation of chitinous materials by bromelain for the preparation of antitumor and antifungal materials.","volume":"99","author":"Wang","year":"2008","journal-title":"Bioresour Technol"},{"key":"R35-3-20210227","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/07357907.2013.784777","article-title":"Anticancer property of bromelain with therapeutic potential in malignant peritoneal mesothelioma.","volume":"31","author":"Pillai","year":"2013","journal-title":"Cancer Invest"},{"key":"R36-3-20210227","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/biof.121","article-title":"Pineapple bromelain induces autophagy, facilitating apoptotic response in mammary carcinoma cells.","volume":"36","author":"Bhui","year":"2010","journal-title":"Biofactors"},{"key":"R37-3-20210227","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.4161\/cbt.8.13.8844","article-title":"Functional targeting of the MUC1 oncogene in human cancers.","volume":"8","author":"Kufe","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"R40-3-20210227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/187152506775268785","article-title":"Cardiotoxicity of 5-fluorouracil.","volume":"4","author":"Alter","year":"2006","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"R41-3-20210227","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1055\/s-2007-990221","article-title":"In vivo antitumoral activity of stem pineapple (Ananas comosus) bromelain.","volume":"73","author":"Baez","year":"2007","journal-title":"Planta Med"},{"key":"R42-3-20210227","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1747-4949.2008.00202.x","article-title":"Early cerebrovascular impairment: new insights and controversies.","volume":"3","author":"Birns","year":"2008","journal-title":"Int J Stroke"},{"key":"R43-3-20210227","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent.","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"R44-3-20210227","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.canlet.2009.08.001","article-title":"Bromelains activity and potential as an anti-cancer agent: current evidence and perspectives.","volume":"290","author":"Chobotova","year":"2010","journal-title":"Cancer Lett"},{"key":"R46-3-20210227","first-page":"483","article-title":"Modulation of murine tumor growth and colonization by bromelaine, an extract of the pineapple plant (Ananas comosum L.).","volume":"19","author":"Beuth","year":"2005","journal-title":"In Vivo"},{"key":"R48-3-20210227","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/sj.neo.7900196","article-title":"Bromelain reversibly inhibits invasive properties of glioma cells.","volume":"3","author":"Tysnes","year":"2001","journal-title":"Neoplasia"},{"key":"R49-3-20210227","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/08820130802083622","article-title":"Bromelain inhibits lipopolysaccharide-induced cytokine production in human THP-1 monocytes via the removal of CD14.","volume":"37","author":"Huang","year":"2008","journal-title":"Immunol Invest"},{"key":"R51-3-20210227","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/bod.2510090408","article-title":"Bioavailability of 125I bromelain after oral administration to rats.","volume":"9","author":"White","year":"1988","journal-title":"Biopharm Drug Dispos"},{"key":"R52-3-20210227","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/sj.bjc.6603972","article-title":"Mucin impedes cytotoxic effect of 5-FU against growth of human pancreatic cancer cells: overcoming cellular barriers for therapeutic gain.","volume":"97","author":"Kalra","year":"2007","journal-title":"Br J Cancer"},{"key":"R53-3-20210227","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/187152007779314044","article-title":"Biochemical mechanisms of cisplatin cytotoxicity.","volume":"7","author":"Cepeda","year":"2007","journal-title":"Anticancer Agents Med Chem"},{"key":"R54-3-20210227","doi-asserted-by":"crossref","first-page":"8923","DOI":"10.1073\/pnas.83.23.8923","article-title":"Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells.","volume":"83","author":"Scanlon","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"R55-3-20210227","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1101\/gad.1126903","article-title":"Ways of dying: multiple pathways to apoptosis.","volume":"17","author":"Adams","year":"2003","journal-title":"Genes Dev"},{"key":"R57-3-20210227","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1002\/1097-0142(19941001)74:7<1847::AID-CNCR2820740704>3.0.CO;2-#","article-title":"Nonsteroidal antiinflammatory drugs and colorectal cancer.","volume":"74","author":"Muscat","year":"1994","journal-title":"Cancer"},{"key":"R58-3-20210227","first-page":"71","article-title":"Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer.","volume":"6","author":"Harris","year":"1999","journal-title":"Oncol Rep"},{"key":"R59-3-20210227","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00001648-199403000-00003","article-title":"Aspirin use and lung, colon, and breast cancer incidence in a prospective study.","volume":"5","author":"Schreinemachers","year":"1994","journal-title":"Epidemiology"},{"key":"R62-3-20210227","first-page":"3696","article-title":"Human mesothelioma samples overexpress both cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (NOS2): in vitro antiproliferative effects of a COX-2 inhibitor.","volume":"60","author":"Marrogi","year":"2000","journal-title":"Cancer Res"},{"key":"R63-3-20210227","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.canlet.2009.03.003","article-title":"Bromelain inhibits COX-2 expression by blocking the activation of MAPK regulated NF-kappa B against skin tumor-initiation triggering mitochondrial death pathway.","volume":"282","author":"Bhui","year":"2009","journal-title":"Cancer Lett"},{"key":"R65-3-20210227","first-page":"4047","article-title":"Expression of Tn and sialyl-Tn antigens in endometrial cancer: its relationship with tumor-produced cyclooxygenase-2, tumor-infiltrated lymphocytes and patient prognosis.","volume":"26","author":"Ohno","year":"2006","journal-title":"Anticancer Res"},{"key":"R70-3-20210227","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1021\/jf0114886","article-title":"Purification and characterization of hydrolase with chitinase and chitosanase activity from commercial stem bromelain.","volume":"50","author":"Hung","year":"2002","journal-title":"J Agric Food Chem"},{"key":"R72-3-20210227","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1096\/fasebj.2.11.2456242","article-title":"The glycoprotein hormones: recent studies of structure-function relationships.","volume":"2","author":"Ryan","year":"1988","journal-title":"FASEB J"},{"key":"R73-3-20210227","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s10120-005-0320-0","article-title":"Molecular-pathological prognostic factors of gastric cancer: a review.","volume":"8","author":"Yasui","year":"2005","journal-title":"Gastric Cancer"},{"key":"R76-3-20210227","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1023\/A:1018580324971","article-title":"Perspectives on the significance of altered glycosylation of glycoproteins in cancer.","volume":"14","author":"Kim","year":"1997","journal-title":"Glycoconj J"},{"key":"R77-3-20210227","doi-asserted-by":"crossref","first-page":"269","DOI":"10.7150\/jca.4592","article-title":"Identification of potential glycoprotein biomarkers in estrogen receptor positive (ER) and negative (ER) human breast cancer tissues by LC-LTQFT-ICR mass spectrometry.","volume":"3","author":"Semaan","year":"2012","journal-title":"J Cancer"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CAD.0000000000000039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:01:16Z","timestamp":1620946876000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001813-201402000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0000000000000039","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}